Corporate Finance
AI Drug Discovery and the New Economics of Pharma Dealmaking
The pharmaceuticals industry is characterised by one of the most extensive R&D processes in the economy. The productivity of the process has been a topic of intense discussion for close to two decades. The underlying metrics indicating the poor productivity of the process are best highlighted by the long timelines
